Management of Bartonella henselae Lymphadenitis Treatment Failure with Azithromycin

Introduction to Treatment Options

• The Centers for Disease Control and Prevention (CDC) recommends that for patients with Bartonella henselae lymphadenitis who fail azithromycin therapy, switching to doxycycline, with or without rifampin, is the recommended next step in management 1, 2, 3

Alternative Treatment Options

• Doxycycline is a first-line treatment for bartonellosis according to CDC guidelines and should be administered for at least 3 months for standard infections (AII) 1, 2, 3
• Erythromycin is another first-line agent that can be considered as an alternative to doxycycline (AII) 1, 2

Special Considerations

• For immunocompromised patients, long-term suppression with doxycycline or a macrolide is recommended after initial treatment (AIII) 2
• Suppressive therapy can be discontinued after 3-4 months when the patient's condition remains stable for >6 months (CIII) 2
• Some specialists recommend continuing therapy until the patient's condition has improved significantly (CIII) 2

Ineffective Treatments to Avoid

• Penicillins and first-generation cephalosporins have no in vivo activity against Bartonella and should not be used (DII) 1, 2, 3
• TMP-SMX and quinolones as monotherapy have variable in vitro activity and inconsistent clinical response and are not recommended (DIII) 1, 2

Monitoring and Adverse Effects

• Patients treated with oral doxycycline should be cautioned about pill-associated ulcerative esophagitis, which occurs most often when a dose is taken with only a small amount of liquid or at night just before retiring (AIII) 1, 2
• If there is no improvement with the alternative regimen within 1-2 weeks, consider further diagnostic evaluation to rule out other causes of lymphadenopathy 4

Treatment Duration

• For uncomplicated lymphadenitis that has failed initial therapy, treatment should be administered for at least 3 months (AII) 1, 2, 3

Treatment of Bartonella henselae Lymphadenitis After Azithromycin Failure

First-Line Alternative Treatment Options

• For children, the recommended doxycycline dosage is 2-4 mg/kg body weight (maximum 100-200 mg/day) per day orally or IV once daily or divided into 2 doses, according to the MMWR Recommendations and Reports 5
• Erythromycin (30-50 mg/kg body weight, maximum 2 g/day) is an alternative first-line agent that can be considered, especially in younger children where doxycycline may not be preferred, as per the MMWR Recommendations and Reports 5

Second-Line Treatment Options

• Rifampin (20 mg/kg body weight, maximum 600 mg/day) can be used in combination with doxycycline or erythromycin for more severe infections, as recommended by the MMWR Recommendations and Reports 5
• Clarithromycin (15 mg/kg body weight, maximum 1 g/day per day orally divided into 2 doses) may be considered as an alternative macrolide, according to the MMWR Recommendations and Reports 5

Treatment Duration

• Longer treatment duration may be needed for patients with more extensive disease or slower response, as suggested by the MMWR Recommendations and Reports 6